Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
55.2M
-
Number of holders
-
91
-
Total 13F shares, excl. options
-
27.2M
-
Shares change
-
-128K
-
Total reported value, excl. options
-
$194M
-
Value change
-
-$5M
-
Put/Call ratio
-
13.24
-
Number of buys
-
39
-
Number of sells
-
-48
-
Price
-
$7.15
Significant Holders of Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) as of Q4 2020
114 filings reported holding VYGR - Voyager Therapeutics, Inc. - Common Stock, $0.001 par value as of Q4 2020.
Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) has 91 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 27.2M shares
of 55.2M outstanding shares and own 49.2% of the company stock.
Largest 10 shareholders include TRV GP III, LLC (6.39M shares), ARMISTICE CAPITAL, LLC (3.39M shares), Bellevue Group AG (2.71M shares), BlackRock Inc. (2.53M shares), VANGUARD GROUP INC (2.42M shares), Clearbridge Investments, LLC (1.39M shares), CITADEL ADVISORS LLC (834K shares), RENAISSANCE TECHNOLOGIES LLC (830K shares), MORGAN STANLEY (716K shares), and JPMORGAN CHASE & CO (612K shares).
This table shows the top 91 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.